AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Winston Pharmaceuticals, Inc.

$0 -$0.00 (-66.67%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0
Day Range
$0 - $0
Year Range
$0$0
Market Cap
7.74K
AVG Volume
15.11K
Trailing/Forward PE
-0/-
PEG ratio
-0
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (USD) · TTM
0500K1M1.5M07 Q408 Q108 Q208 Q308 Q409 Q109 Q209 Q309 Q410 Q1
WPHM Revenue (USD) · TTM by quarter
PeriodRevenue (USD) · TTM
10 Q11.37M
09 Q41.39M
09 Q31.4M
09 Q21.06M
09 Q1692.53K
08 Q4352.55K
08 Q36.91K
08 Q20
08 Q1275K
07 Q4275K
Net Income (USD) · TTM
-4M-3M-2M-1M007 Q408 Q108 Q208 Q308 Q409 Q109 Q209 Q309 Q410 Q1
WPHM Net Income (USD) · TTM by quarter
PeriodNet Income (USD) · TTM
10 Q1-2.34M
09 Q4-2.66M
09 Q3-3.36M
09 Q2-3.77M
09 Q1-3.2M
08 Q4-2.49M
08 Q3-1.28M
08 Q2-180.1K
08 Q1-464.42K
07 Q4-470.11K
Operating Income (USD) · TTM
-4M-3M-2M-1M007 Q408 Q108 Q208 Q308 Q409 Q109 Q209 Q309 Q410 Q1
WPHM Operating Income (USD) · TTM by quarter
PeriodOperating Income (USD) · TTM
10 Q1-2.41M
09 Q4-2.74M
09 Q3-3.47M
09 Q2-3.89M
09 Q1-3.25M
08 Q4-2.54M
08 Q3-1.32M
08 Q2-220.17K
08 Q1-502.64K
07 Q4-501.68K
EBITDA (USD) · TTM
-4M-3M-2M-1M007 Q408 Q108 Q208 Q308 Q409 Q109 Q209 Q309 Q410 Q1
WPHM EBITDA (USD) · TTM by quarter
PeriodEBITDA (USD) · TTM
10 Q1-2.41M
09 Q4-2.73M
09 Q3-3.46M
09 Q2-3.88M
09 Q1-3.24M
08 Q4-2.53M
08 Q3-1.32M
08 Q2-220.17K
08 Q1-501.52K
07 Q4-500.56K
Cash Flows (USD) · TTM
-6M-4M-2M006 Q407 Q107 Q207 Q307 Q408 Q108 Q209 Q309 Q410 Q1
WPHM Cash Flows (USD) · TTM by quarter
PeriodCash Flows (USD) · TTM
10 Q1-3.54M
09 Q4-4.2M
09 Q3-3.31M
08 Q2-163.93K
08 Q1-193.44K
07 Q4-216.37K
07 Q3-172.99K
07 Q2-174.58K
07 Q1-134.28K
06 Q4-71.09K
EPS (USD) · TTM
-0.15-0.1-0.05-007 Q408 Q108 Q208 Q308 Q409 Q109 Q209 Q309 Q410 Q1
WPHM EPS (USD) · TTM by quarter
PeriodEPS (USD) · TTM
10 Q1-0.03
09 Q4-0.03
09 Q3-0.05
09 Q2-0.06
09 Q1-0.08
08 Q4-0.09
08 Q3-0.1
08 Q2-0.08
08 Q1-0.06
07 Q4-0.11
Expenses (USD) · TTM
02M4M6MR&DSG&ACapex07 Q408 Q108 Q208 Q308 Q409 Q109 Q209 Q309 Q410 Q1
WPHM Expenses (USD) · TTM by quarter
PeriodExpenses (USD) · TTM
07 Q30
07 Q20
07 Q10
06 Q40
10 Q13.78M
09 Q44.13M
09 Q34.86M
09 Q24.93M
09 Q13.94M
08 Q42.89M
08 Q31.33M
08 Q2220.17K
08 Q1776.52K
07 Q4775.55K
Shares Outstanding · TTM
-30K-20K-10K006 Q407 Q107 Q207 Q307 Q408 Q108 Q209 Q309 Q410 Q1
WPHM Shares Outstanding · TTM by quarter
PeriodShares Outstanding · TTM
10 Q1-29.15K
09 Q4-29.15K
09 Q3-29.15K
08 Q20
08 Q10
07 Q40
07 Q30
07 Q20
07 Q10
06 Q40
Winston Pharmaceuticals, Inc.
WPHM
Stockpicker

Video analysis: WPHM

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.